Andrew Shutes‐David

476 total citations
12 papers, 344 citations indexed

About

Andrew Shutes‐David is a scholar working on Psychiatry and Mental health, Molecular Biology and Neurology. According to data from OpenAlex, Andrew Shutes‐David has authored 12 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Psychiatry and Mental health, 3 papers in Molecular Biology and 3 papers in Neurology. Recurrent topics in Andrew Shutes‐David's work include Dementia and Cognitive Impairment Research (4 papers), Machine Learning in Healthcare (3 papers) and Chronic Disease Management Strategies (2 papers). Andrew Shutes‐David is often cited by papers focused on Dementia and Cognitive Impairment Research (4 papers), Machine Learning in Healthcare (3 papers) and Chronic Disease Management Strategies (2 papers). Andrew Shutes‐David collaborates with scholars based in United States, Sweden and Italy. Andrew Shutes‐David's co-authors include Elaine R. Peskind, Denes V. Agoston, Debby W. Tsuang, Tiffany A. Greenwood, Stephen Thielke, Yijun Shao, Qing Zeng, Chang‐En Yu, Lesley Leong and Douglas Galasko and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Alzheimer s & Dementia.

In The Last Decade

Andrew Shutes‐David

10 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Shutes‐David United States 7 123 118 87 79 57 12 344
Merav Catalogna Israel 13 179 1.5× 48 0.4× 97 1.1× 76 1.0× 43 0.8× 24 453
Zilan Wang China 10 109 0.9× 46 0.4× 54 0.6× 70 0.9× 64 1.1× 31 324
Jonathan M. Schott United Kingdom 8 143 1.2× 56 0.5× 72 0.8× 60 0.8× 79 1.4× 18 295
Je Yeong Sone United States 5 71 0.6× 68 0.6× 71 0.8× 57 0.7× 117 2.1× 8 305
Aiesha Ahmed United States 9 182 1.5× 41 0.3× 50 0.6× 51 0.6× 22 0.4× 28 349
Ameet C. Patel United States 7 49 0.4× 32 0.3× 58 0.7× 88 1.1× 71 1.2× 16 349
Kogulavadanan Arumaithurai United States 7 49 0.4× 24 0.2× 37 0.4× 73 0.9× 21 0.4× 17 254
Niange Xia China 11 36 0.3× 51 0.4× 62 0.7× 116 1.5× 26 0.5× 28 323
Dean Sarco United States 10 65 0.5× 218 1.8× 40 0.5× 150 1.9× 41 0.7× 16 633
Emilie Vierron France 11 50 0.4× 34 0.3× 39 0.4× 56 0.7× 100 1.8× 17 423

Countries citing papers authored by Andrew Shutes‐David

Since Specialization
Citations

This map shows the geographic impact of Andrew Shutes‐David's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Shutes‐David with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Shutes‐David more than expected).

Fields of papers citing papers by Andrew Shutes‐David

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Shutes‐David. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Shutes‐David. The network helps show where Andrew Shutes‐David may publish in the future.

Co-authorship network of co-authors of Andrew Shutes‐David

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Shutes‐David. A scholar is included among the top collaborators of Andrew Shutes‐David based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Shutes‐David. Andrew Shutes‐David is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Shutes‐David, Andrew, et al.. (2023). Pimavanserin Treatment for Psychosis in Patients with Dementia with Lewy Bodies: A Case Series. American Journal of Case Reports. 24. e939806–e939806. 2 indexed citations
3.
Shao, Yijun, Andrew Shutes‐David, Steven P. Millard, et al.. (2023). Identifying Probable Dementia in Undiagnosed Black and White Americans Using Machine Learning in Veterans Health Administration Electronic Health Records. Big Data and Cognitive Computing. 7(4). 167–167.
4.
Chen, Sunny, Lesley Leong, Aleen D. Saxton, et al.. (2020). Redefining transcriptional regulation of the APOE gene and its association with Alzheimer’s disease. PLoS ONE. 15(1). e0227667–e0227667. 35 indexed citations
5.
Shutes‐David, Andrew, et al.. (2020). Mild COVID-19 Disease Course With Protracted Delirium in a Cognitively Impaired Patient Over the Age of 85 Years. The Primary Care Companion For CNS Disorders. 22(4). 2 indexed citations
6.
Greenwood, Tiffany A., Andrew Shutes‐David, & Debby W. Tsuang. (2019). Endophenotypes in Schizophrenia: Digging Deeper to Identify Genetic Mechanisms. SHILAP Revista de lepidopterología. 4(2). 31 indexed citations
7.
Shao, Yijun, et al.. (2019). Detection of probable dementia cases in undiagnosed patients using structured and unstructured electronic health records. BMC Medical Informatics and Decision Making. 19(1). 128–128. 60 indexed citations
8.
Tsuang, Debby W., et al.. (2019). P4‐559: DETECTION OF PROBABLE DEMENTIA CASES IN UNDIAGNOSED PATIENTS USING STRUCTURED AND UNSTRUCTURED ELECTRONIC HEALTH RECORDS. Alzheimer s & Dementia. 15(7S_Part_29). 1 indexed citations
9.
Leong, Lesley, Sunny Chen, C. Dirk Keene, et al.. (2018). APOE DNA methylation is altered in Lewy body dementia. Alzheimer s & Dementia. 14(7). 889–894. 22 indexed citations
10.
Tsuang, Debby W., Tiffany A. Greenwood, Suman Jayadev, et al.. (2018). A Genetic Study of Psychosis in Huntington’s Disease: Evidence for the Involvement of Glutamate Signaling Pathways. Journal of Huntington s Disease. 7(1). 51–59. 8 indexed citations
11.
Shofer, Jane B., Eric C. Petrie, Chang-En Yu, et al.. (2017). Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults. Alzheimer s Research & Therapy. 9(1). 48–48. 35 indexed citations
12.
Agoston, Denes V., Andrew Shutes‐David, & Elaine R. Peskind. (2017). Biofluid biomarkers of traumatic brain injury. Brain Injury. 31(9). 1195–1203. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Merav Catalogna Breakdown of academic impact, for papers by Zilan Wang Breakdown of academic impact, for papers by Jonathan M. Schott Breakdown of academic impact, for papers by Je Yeong Sone Breakdown of academic impact, for papers by Aiesha Ahmed Breakdown of academic impact, for papers by Ameet C. Patel Breakdown of academic impact, for papers by Kogulavadanan Arumaithurai Breakdown of academic impact, for papers by Niange Xia Breakdown of academic impact, for papers by Dean Sarco Breakdown of academic impact, for papers by Emilie Vierron
Rankless by CCL
2026